Baker Bros. Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Baker Bros. Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60,155	Closed	-$4.06M	–	119
2018 Q2	$4.06M	Sell	60,155 -155,500	-72%	-$8.7M	0.03%	86
2018 Q1	$11.7M	Sell	215,655 -83,701	-28%	-$4.68M	0.1%	52
2017 Q4	$17.9M	Hold	299,356	–	–	0.16%	48
2017 Q3	$14.5M	Hold	299,356	–	–	0.12%	46
2017 Q2	$15.7M	Hold	299,356	–	–	0.14%	38
2017 Q1	$13.6M	Hold	299,356	–	–	0.11%	43
2016 Q4	$11.3M	Hold	299,356	–	–	0.11%	46
2016 Q3	$11.3M	Hold	299,356	–	–	0.1%	50
2016 Q2	$5.27M	Hold	299,356	–	–	0.06%	72
2016 Q1	$3.64M	Hold	299,356	–	–	0.04%	81
2015 Q4	$7.29M	Hold	299,356	–	–	0.06%	68
2015 Q3	$5.31M	Hold	299,356	–	–	0.05%	76
2015 Q2	$5.28M	Hold	299,356	–	–	0.05%	77
2015 Q1	$9.38M	Hold	299,356	–	–	0.08%	59
2014 Q4	$8.74M	Hold	299,356	–	–	0.09%	52
2014 Q3	$6.19M	Hold	299,356	–	–	0.08%	56
2014 Q2	$7.42M	Hold	299,356	–	–	0.09%	53
2014 Q1	$6.34M	Sell	299,356 -644	-0.2%	-$13K	0.08%	66
2013 Q4	$5.39M	Buy	+300,000	New	+$3.91M	0.08%	62

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Baker Bros. Advisors's AERI Position: Q3 2018 in Review

Baker Bros. Advisors sold out of Aerie Pharmaceuticals (AERI) in Q3 2018, closing a stake of 60,155 shares — an estimated $4.06M sold.

Baker Bros. Advisors first reported a position in AERI in Q4 2013 and held it in 19 quarters. The position peaked at $17.9M in Q4 2017. 176 funds tracked by Wall St. Rank hold AERI as of Q3 2018.

Baker Bros. Advisors reported no remaining Aerie Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Baker Bros. Advisors sold 60,155 Aerie Pharmaceuticals shares in Q3 2018, an estimated $4.06M.
Baker Bros. Advisors first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 19 quarters.
Baker Bros. Advisors's Aerie Pharmaceuticals position peaked at $17.9M in Q4 2017.
176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.